title: Can WR-2721 be improved upon?
authors.affiliation: Department of Radiation Therapy, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111.
authors.forename: D Q
authors.initials: DQ
authors.lastname: Brown
authors.forename: W J
authors.initials: WJ
authors.lastname: Graham
authors.forename: L J
authors.initials: LJ
authors.lastname: MacKenzie
authors.forename: J W
authors.initials: JW
authors.lastname: Pittock
authors.forename: L M
authors.initials: LM
authors.lastname: Shaw
mesh_terms: D004999:Amifostine / Q000627:therapeutic use* / Q000633:toxicity; D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D004064:Digestive System / Q000187:drug effects; D006413:Hematopoietic System / Q000187:drug effects; D009381:Neoplasms, Radiation-Induced / Q000517:prevention & control; D009946:Organothiophosphorus Compounds / Q000627:therapeutic use*; D011833:Radiation Injuries, Experimental / Q000517:prevention & control*; D011837:Radiation-Protective Agents / Q000627:therapeutic use* / Q000633:toxicity
chemical_list: D009946:Organothiophosphorus Compounds; D011837:Radiation-Protective Agents; D004999:Amifostine